Skip to contentScholarGate
LibraryBookshelfDeskReview StudioAssistant
Sign in
On this page
IntuitionHow it worksWhen to use itStrengths & limitationsCommon pitfallsApplicationsFrequently asked🔒 Read the full methodSourcesRelated methods
Cite this pageSpotted an issue on this page? Report or suggest a fix →
Home›Pharmacometrics›Pharmacokinetic Compartment Model
Regression modelPharmacokinetics

Pharmacokinetic Compartment Model

Compartmental Pharmacokinetic Models · Also known as: Mammillary Compartment Model, Multi-Compartment PK Model, Compartmental Analysis, Farmakokinetik Kompartman Modeli

The pharmacokinetic compartment model represents the body as one or more hypothetical compartments interconnected by first-order rate processes, describing how a drug is absorbed, distributed, and eliminated over time. Systematized by Gibaldi and Perrier in 1982, these models use ordinary differential equations to characterize plasma concentration-time profiles. They are the cornerstone of drug development, dosage regimen design, and regulatory submission pharmacokinetic analyses.

ScholarGate
  1. Regression model
  2. v1
  3. 1 Sources
  4. PUBLISHED
Cite this page →
Tools & resources
Download slides
Learn & explore

Read the full method

Members only

Sign in with a free account to read this section.

Sign in

Method map

The neighbourhood of related methods — select a node to explore.

Pharmacokinetic Compartment Model
Bioequivalence AnalysisEmax ModelPopulation Pharmacokinet…Therapeutic Drug Monitor…

When to use it

Use compartment models when you have serial plasma concentration-time data following single or multiple doses and need to estimate fundamental PK parameters (CL, V_d, half-life) for dosing optimization, bioequivalence, or drug-drug interaction assessment. The one-compartment model suits drugs with rapid distribution; the two-compartment model is required when a distinct distribution phase is visible. Assumptions include linear (first-order) kinetics, time-invariant parameters, and homogeneous mixing within each compartment. Nonlinear kinetics (e.g., Michaelis-Menten saturation) require nonlinear compartmental or empirical models instead.

Strengths & limitations

Strengths
  • Provides mechanistically interpretable parameters (CL, V_d, half-life) directly linking biology to drug behavior
  • Enables simulation of concentration-time profiles for untested dosing regimens and patient populations
  • Analytically tractable closed-form solutions exist for one- and two-compartment IV bolus scenarios
  • Widely accepted by regulatory agencies (FDA, EMA) as the standard framework for NDA/MAA PK submissions
Limitations
  • Compartments are mathematical constructs, not anatomical structures, limiting direct physiological interpretation
  • Assumes linear, time-invariant kinetics, which fails for drugs exhibiting saturable binding, autoinduction, or time-dependent PK
  • Requires rich, well-timed plasma sampling; sparse data lead to poor identifiability of multi-compartment parameters
  • Model selection (number of compartments) can be ambiguous when goodness-of-fit criteria give similar results

Frequently asked

How do I decide between a one-compartment and a two-compartment model?

Inspect the semi-logarithmic plasma concentration-time plot: a single linear decline supports one compartment, while a biphasic curve with a distinct rapid distribution phase followed by slower terminal elimination indicates two compartments. Formal selection uses the Akaike Information Criterion (AIC) or likelihood ratio test, combined with visual inspection of residuals and the precision of parameter estimates.

What is the clinical significance of the volume of distribution?

Volume of distribution (V_d) quantifies how extensively a drug distributes beyond plasma into tissues. A large V_d (greater than total body water, roughly 42 L in a 70 kg adult) indicates extensive tissue binding or lipophilicity, which prolongs half-life and means plasma drug levels underrepresent total body load — important when assessing overdose or dialyzability.

Can compartment models handle oral dosing?

Yes. For extravascular routes, a first-order absorption compartment is prepended to the central compartment, adding an absorption rate constant k_a to the model. The plasma concentration then follows a difference of exponentials: C(t) = [F·D·k_a / (V·(k_a − k_el))] · (e^(−k_el·t) − e^(−k_a·t)), where F is bioavailability. Flip-flop kinetics must be checked when k_el exceeds k_a.

Sources

  1. Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). Marcel Dekker. ISBN: 978-0-8247-1042-2

How to cite this page

ScholarGate. (2026, June 2). Compartmental Pharmacokinetic Models. ScholarGate. https://scholargate.app/en/pharmacometrics/pharmacokinetic-compartment-model

Related methods

Bioequivalence AnalysisEmax ModelPopulation Pharmacokinetics

Which method?

Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.

  • Bioequivalence AnalysisPharmacometrics↔ compare
  • Emax ModelPharmacometrics↔ compare
  • Population PharmacokineticsPharmacometrics↔ compare
Compare side by side →

Referenced by

Bioequivalence AnalysisEmax ModelPopulation PharmacokineticsTherapeutic Drug Monitoring

Similar methods

Physiologically Based PharmacokineticsPopulation PharmacokineticsTarget-Mediated Drug DispositionPopulation PharmacodynamicsMichaelis-Menten KineticsAllometric PK ScalingPET Kinetic ModelingEmax Model

Related reference concepts

One-, Two-, and Multi-Compartment ModelsPharmacokinetic Modeling and Half-LifeKinetic Parameters and ModelingTissue CompartmentalizationPharmacokineticsPharmacokinetic Parameters (Clearance, Half-Life, Volume of Distribution)

Spotted an issue on this page? Report or suggest a fix →

ScholarGate — Pharmacokinetic Compartment Model (Compartmental Pharmacokinetic Models). Retrieved 2026-07-21 from https://scholargate.app/en/pharmacometrics/pharmacokinetic-compartment-model · Dataset: https://doi.org/10.5281/zenodo.20539026
Quick facts
Originator
Gibaldi & Perrier
Year
1982
Type
Deterministic ODE-based pharmacokinetic model
Subfamily
Pharmacokinetics
EstimationMethod
Nonlinear least squares or maximum likelihood
ParameterCount
2 (one-compartment) to 6+ (two-compartment)
Related methods
Bioequivalence AnalysisEmax ModelPopulation Pharmacokinetics
ScholarGate

A content-first reference library for research methods — what each one is, how it works, and where it comes from.

Open data (CC-BY)

Explore

  • Library
  • Search the library…
  • Browse by field
  • Fields
  • Journey
  • Compare
  • Which method?

Reference

  • Subjects
  • Atlas
  • Glossary
  • Methodology
  • Philosophy

Your tools

  • Bookshelf
  • Desk
  • Chat

Company

  • About
  • Pricing
  • Contact
  • Suggest a method

Entries are compiled from published sources for reference. Verifying the accuracy and suitability of any information for your own use remains your responsibility.

© 2026 ScholarGate · A research-method reference library
  • Privacy
  • Cookies
  • Terms
  • Delete account